AHNS Presidential Award: Integrating Emerging Technologies for Head and Neck Cancer Translational Clinical and Epidemiologic Research
Supports research using advanced technologies to improve early detection, prevention, and treatment of head and neck cancer through translational clinical and epidemiologic studies.
Funder: American Academy of Otolaryngology - Head and Neck Surgery
Due Dates (Anticipated): December 2026 (Letter of Intent) | January 2027 (Full Application)
Funding Amounts: Up to $15,000 for a 12-month, non-renewable project; indirect costs capped at 10% and total costs may not exceed $15,000.
Summary: Supports innovative research integrating emerging technologies into clinical and epidemiologic studies of head and neck cancer to advance early detection, prevention, and treatment.
Description
This award supports multidisciplinary research projects that integrate emerging technologies—such as single-cell and spatial multi-omics, AI-enabled digital pathology, advanced imaging, wearable/remote monitoring devices, and real-time data integration platforms—into translational clinical and epidemiologic studies of head and neck cancer. The goal is to advance understanding of disease mechanisms, identify novel biomarkers, and develop patient-centered intervention strategies, focusing on early detection, precision prevention, and effective, cost-efficient treatment, particularly for patients with locally advanced disease or treatment-related morbidity. Projects should generate novel insights or practical applications directly informing early detection, risk prediction, or treatment response, and may include mapping tumor heterogeneity, developing AI models for risk stratification, integrating wearable technologies for monitoring, and addressing disparities in outcomes. Collaborative, multidisciplinary approaches and open science practices are encouraged.
